These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease. van Zuuren EJ; Fedorowicz Z Cochrane Database Syst Rev; 2013 Jun; (6):CD010155. PubMed ID: 23760785 [TBL] [Abstract][Full Text] [Related]
44. Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II. Woods GM; Jorgensen JH; Waclawiw MA; Reid C; Wang W; Pegelow CH; Rogers ZR; Iyer RV; Holbrook CT; Kinney TR; Vichinsky E; DeBaun MR; Grossman NJ; Thomas MD; Falletta JM J Pediatr Hematol Oncol; 1997; 19(4):327-33. PubMed ID: 9256832 [TBL] [Abstract][Full Text] [Related]
45. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192 [TBL] [Abstract][Full Text] [Related]
46. Piracetam for reducing the incidence of painful sickle cell disease crises. Al Hajeri A; Fedorowicz Z Cochrane Database Syst Rev; 2016 Feb; 2(2):CD006111. PubMed ID: 26869149 [TBL] [Abstract][Full Text] [Related]
47. Treatments for priapism in boys and men with sickle cell disease. Chinegwundoh FI; Smith S; Anie KA Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004198. PubMed ID: 28926088 [TBL] [Abstract][Full Text] [Related]
48. Piracetam for reducing the incidence of painful sickle cell disease crises. Al Hajeri AA; Fedorowicz Z; Omran A; Tadmouri GO Cochrane Database Syst Rev; 2007 Apr; (2):CD006111. PubMed ID: 17443614 [TBL] [Abstract][Full Text] [Related]
49. Treatment for avascular necrosis of bone in people with sickle cell disease. Martí-Carvajal AJ; Solà I; Agreda-Pérez LH Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004344. PubMed ID: 31803937 [TBL] [Abstract][Full Text] [Related]
50. Oral protein calorie supplementation for children with chronic disease. Francis DK; Smith J; Saljuqi T; Watling RM Cochrane Database Syst Rev; 2015 May; 2015(5):CD001914. PubMed ID: 26014160 [TBL] [Abstract][Full Text] [Related]
51. Interventions for treating intrahepatic cholestasis in people with sickle cell disease. Martí-Carvajal AJ; Martí-Amarista CE Cochrane Database Syst Rev; 2020 Jun; 6(6):CD010985. PubMed ID: 32567054 [TBL] [Abstract][Full Text] [Related]
52. Antibiotics for treating osteomyelitis in people with sickle cell disease. Martí-Carvajal AJ; Agreda-Pérez LH Cochrane Database Syst Rev; 2016 Nov; 11(11):CD007175. PubMed ID: 27841931 [TBL] [Abstract][Full Text] [Related]
53. Treatment of dental complications in sickle cell disease. Mulimani P; Ballas SK; Abas AB; Karanth L Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011633. PubMed ID: 31841224 [TBL] [Abstract][Full Text] [Related]
54. Psychological therapies for sickle cell disease and pain. Anie KA; Green J Cochrane Database Syst Rev; 2015 May; 2015(5):CD001916. PubMed ID: 25966336 [TBL] [Abstract][Full Text] [Related]
55. Vaccines for preventing invasive salmonella infections in people with sickle cell disease. Odey F; Okomo U; Oyo-Ita A Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006975. PubMed ID: 30521695 [TBL] [Abstract][Full Text] [Related]